BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Leffler J, Bengtsson AA, Blom AM. The complement system in systemic lupus erythematosus: an update. Ann Rheum Dis 2014;73:1601-6. [PMID: 24845390 DOI: 10.1136/annrheumdis-2014-205287] [Cited by in Crossref: 138] [Cited by in F6Publishing: 124] [Article Influence: 17.3] [Reference Citation Analysis]
Number Citing Articles
1 Xiao ZX, Hu X, Zhang X, Chen Z, Wang J, Jin K, Cao FL, Sun B, Bellanti JA, Olsen N, Zheng SG. High salt diet accelerates the progression of murine lupus through dendritic cells via the p38 MAPK and STAT1 signaling pathways. Signal Transduct Target Ther 2020;5:34. [PMID: 32296043 DOI: 10.1038/s41392-020-0139-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
2 Hulsebus HJ, O'Conner SD, Smith EM, Jie C, Bohlson SS. Complement Component C1q Programs a Pro-Efferocytic Phenotype while Limiting TNFα Production in Primary Mouse and Human Macrophages. Front Immunol 2016;7:230. [PMID: 27379094 DOI: 10.3389/fimmu.2016.00230] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
3 Zhao W, Wu C, Li LJ, Fan YG, Pan HF, Tao JH, Leng RX, Ye DQ. RNAi Silencing of HIF-1α Ameliorates Lupus Development in MRL/lpr Mice. Inflammation 2018;41:1717-30. [PMID: 30043119 DOI: 10.1007/s10753-018-0815-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
4 Wang S, Wang F, Wang X, Zhang Y, Song L. Elevated Creatinine Clearance in Lupus Nephritis patients with Normal Creatinine. Int J Med Sci 2021;18:1449-55. [PMID: 33628102 DOI: 10.7150/ijms.51117] [Reference Citation Analysis]
5 Hiraki LT, Silverman ED. Genomics of Systemic Lupus Erythematosus: Insights Gained by Studying Monogenic Young-Onset Systemic Lupus Erythematosus. Rheum Dis Clin North Am 2017;43:415-34. [PMID: 28711143 DOI: 10.1016/j.rdc.2017.04.005] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
6 Su Z, Niu Q, Huang Z, Yang B, Zhang J. Association of nucleotide-binding oligomerization domain-like receptor family pyrin domain-containing protein 3 polymorphisms with systemic lupus erythematosus disease activity and biomarker levels: A case-control study in Chinese population. Medicine (Baltimore) 2020;99:e21888. [PMID: 32871918 DOI: 10.1097/MD.0000000000021888] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Wan Z, Pascual V. Breaching self-tolerance by targeting the gatekeeper. J Exp Med 2021;218:e20210322. [PMID: 33847707 DOI: 10.1084/jem.20210322] [Reference Citation Analysis]
8 Chen H, Tsai L, Lee K, Chen Y, Hung W, Chen D. Genetic association of complement component 2 polymorphism with systemic lupus erythematosus: The C2 polymorphism in association with SLE. Tissue Antigens 2015;86:122-33. [DOI: 10.1111/tan.12602] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
9 Csorba K, Schirmbeck LA, Tuncer E, Ribi C, Roux-Lombard P, Chizzolini C, Huynh-Do U, Vanhecke D, Trendelenburg M. Anti-C1q Antibodies as Occurring in Systemic Lupus Erythematosus Could Be Induced by an Epstein-Barr Virus-Derived Antigenic Site. Front Immunol 2019;10:2619. [PMID: 31787984 DOI: 10.3389/fimmu.2019.02619] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
10 Nikitin PA, Rose EL, Byun TS, Parry GC, Panicker S. C1s Inhibition by BIVV009 (Sutimlimab) Prevents Complement-Enhanced Activation of Autoimmune Human B Cells In Vitro. J Immunol 2019;202:1200-9. [PMID: 30635392 DOI: 10.4049/jimmunol.1800998] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
11 Bandyopadhyay S, Connolly SE, Jabado O, Ye J, Kelly S, Maldonado MA, Westhovens R, Nash P, Merrill JT, Townsend RM. Identification of biomarkers of response to abatacept in patients with SLE using deconvolution of whole blood transcriptomic data from a phase IIb clinical trial. Lupus Sci Med 2017;4:e000206. [PMID: 29214034 DOI: 10.1136/lupus-2017-000206] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
12 Sodi A, Passerini I, Bacherini D, Boni L, Palchetti S, Murro V, Caporossi O, Mucciolo DP, Franco F, Vannozzi L, Torricelli F, Pelo E, Rizzo S, Virgili G. CFH Y402H polymorphism in Italian patients with age-related macular degeneration, retinitis pigmentosa, and Stargardt disease. Ophthalmic Genet 2018;39:699-705. [PMID: 30285522 DOI: 10.1080/13816810.2018.1525753] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
13 Zhao Y, Wei W, Liu ML. Extracellular vesicles and lupus nephritis - New insights into pathophysiology and clinical implications. J Autoimmun 2020;115:102540. [PMID: 32893081 DOI: 10.1016/j.jaut.2020.102540] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
14 Freier D, Buttgereit F. [Controlling glucocorticoid treatment in critically ill patients with rheumatism exemplified by systemic lupus erythematosus]. Z Rheumatol 2019;78:947-54. [PMID: 31410548 DOI: 10.1007/s00393-019-00686-1] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
15 Yung S, Chan TM. Mechanisms of Kidney Injury in Lupus Nephritis - the Role of Anti-dsDNA Antibodies. Front Immunol 2015;6:475. [PMID: 26441980 DOI: 10.3389/fimmu.2015.00475] [Cited by in Crossref: 64] [Cited by in F6Publishing: 56] [Article Influence: 9.1] [Reference Citation Analysis]
16 Moulton VR, Suarez-Fueyo A, Meidan E, Li H, Mizui M, Tsokos GC. Pathogenesis of Human Systemic Lupus Erythematosus: A Cellular Perspective. Trends Mol Med 2017;23:615-35. [PMID: 28623084 DOI: 10.1016/j.molmed.2017.05.006] [Cited by in Crossref: 158] [Cited by in F6Publishing: 132] [Article Influence: 31.6] [Reference Citation Analysis]
17 Mahto H, Pati A, Sahu SK, Sharma HP, Padhi A, Panda AK. Association of MBL-2 gene polymorphisms with systemic lupus erythematosus: an updated meta-analysis and trial sequential analysis. Lupus 2020;29:1227-37. [PMID: 32635881 DOI: 10.1177/0961203320939156] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
18 Costagliola G, Cappelli S, Consolini R. Autoimmunity in Primary Immunodeficiency Disorders: An Updated Review on Pathogenic and Clinical Implications. J Clin Med 2021;10:4729. [PMID: 34682853 DOI: 10.3390/jcm10204729] [Reference Citation Analysis]
19 Mohan C, Putterman C. Genetics and pathogenesis of systemic lupus erythematosus and lupus nephritis. Nat Rev Nephrol 2015;11:329-41. [PMID: 25825084 DOI: 10.1038/nrneph.2015.33] [Cited by in Crossref: 181] [Cited by in F6Publishing: 165] [Article Influence: 25.9] [Reference Citation Analysis]
20 Upton J. Immunodeficiencies with hypergammaglobulinemia: a review. LymphoSign Journal 2015;2:57-73. [DOI: 10.14785/lpsn-2014-0019] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
21 Cieslinski JZ, Skare TL, Nisihara R, De Messias-Reason IJ, Utiyama SRR. Mannose-binding lectin serum levels in patients with systemic lupus erythematosus: association with thrombocytopaenia and seizure. Lupus 2018;27:372-9. [PMID: 28786770 DOI: 10.1177/0961203317722846] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
22 Dijkstra DJ, Joeloemsingh JV, Bajema IM, Trouw LA. Complement activation and regulation in rheumatic disease. Seminars in Immunology 2019;45:101339. [DOI: 10.1016/j.smim.2019.101339] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
23 Gusev EY, Zotova NV. Cellular Stress and General Pathological Processes. Curr Pharm Des 2019;25:251-97. [PMID: 31198111 DOI: 10.2174/1381612825666190319114641] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 4.5] [Reference Citation Analysis]
24 Su JY, Luo X, Zhang XJ, Deng XL, Su ZR, Zhou L, Li SS, Dai Z, Xu Y, Lai XP. Immunosuppressive activity of pogostone on T cells: Blocking proliferation via S phase arrest. Int Immunopharmacol 2015;26:328-37. [PMID: 25912345 DOI: 10.1016/j.intimp.2015.04.019] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
25 Frazer-Abel A, Kirschfink M, Prohászka Z. Expanding Horizons in Complement Analysis and Quality Control. Front Immunol 2021;12:697313. [PMID: 34434189 DOI: 10.3389/fimmu.2021.697313] [Reference Citation Analysis]
26 Cheng Q, Chen M, Chen X, Chen X, Jiang H, Wu H, Du Y. Novel Long Non-coding RNA Expression Profile of Peripheral Blood Mononuclear Cells Reveals Potential Biomarkers and Regulatory Mechanisms in Systemic Lupus Erythematosus. Front Cell Dev Biol 2021;9:639321. [PMID: 34150746 DOI: 10.3389/fcell.2021.639321] [Reference Citation Analysis]
27 Morse MD, Clark KL, Cascalho M, Kahlenberg JM. Caspase-1 is required for maintenance of marginal zone B cells in pristane-induced lupus. Lupus 2016;25:81-7. [PMID: 26405027 DOI: 10.1177/0961203315606982] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
28 Pikman R, Kivity S, Levy Y, Arango MT, Chapman J, Yonath H, Shoenfeld Y, Gofrit SG. Neuropsychiatric SLE: from animal model to human. Lupus 2017;26:470-7. [PMID: 28394237 DOI: 10.1177/0961203317694261] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
29 Caster DJ, Merchant ML, Klein JB, Powell DW. Precision medicine in lupus nephritis: can biomarkers get us there? Transl Res 2018;201:26-39. [PMID: 30179587 DOI: 10.1016/j.trsl.2018.08.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
30 Kim AHJ, Strand V, Sen DP, Fu Q, Mathis NL, Schmidt MJ, Bruchas RR, Staten NR, Olson PK, Stiening CM, Atkinson JP. Association of Blood Concentrations of Complement Split Product iC3b and Serum C3 With Systemic Lupus Erythematosus Disease Activity. Arthritis Rheumatol 2019;71:420-30. [PMID: 30294950 DOI: 10.1002/art.40747] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 5.7] [Reference Citation Analysis]
31 Okrój M, Potempa J. Complement Activation as a Helping Hand for Inflammophilic Pathogens and Cancer. Front Immunol 2018;9:3125. [PMID: 30687327 DOI: 10.3389/fimmu.2018.03125] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
32 Ekinci Z, Ozturk K. Systemic lupus erythematosus with C1q deficiency: treatment with fresh frozen plasma. Lupus 2018;27:134-8. [PMID: 29113537 DOI: 10.1177/0961203317741565] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
33 Muñoz LE, Leppkes M, Fuchs TA, Hoffmann M, Herrmann M. Missing in action-The meaning of cell death in tissue damage and inflammation. Immunol Rev 2017;280:26-40. [PMID: 29027227 DOI: 10.1111/imr.12569] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
34 Tsai CY, Shen CY, Liu CW, Hsieh SC, Liao HT, Li KJ, Lu CS, Lee HT, Lin CS, Wu CH, Kuo YM, Yu CL. Aberrant Non-Coding RNA Expression in Patients with Systemic Lupus Erythematosus: Consequences for Immune Dysfunctions and Tissue Damage. Biomolecules 2020;10:E1641. [PMID: 33291347 DOI: 10.3390/biom10121641] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
35 Prohászka Z, Kirschfink M, Frazer-Abel A. Complement analysis in the era of targeted therapeutics. Mol Immunol 2018;102:84-8. [PMID: 29933889 DOI: 10.1016/j.molimm.2018.06.001] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
36 Ferrero E. Using regulatory genomics data to interpret the function of disease variants and prioritise genes from expression studies. F1000Res 2018;7:121. [PMID: 29568492 DOI: 10.12688/f1000research.13577.2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
37 Troldborg A, Thiel S, Trendelenburg M, Friebus-Kardash J, Nehring J, Steffensen R, Hansen SWK, Laska MJ, Deleuran B, Jensenius JC, Voss A, Stengaard-Pedersen K. The Lectin Pathway of Complement Activation in Patients with Systemic Lupus Erythematosus. J Rheumatol 2018;45:1136-44. [PMID: 29907670 DOI: 10.3899/jrheum.171033] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 5.3] [Reference Citation Analysis]
38 Qian B, Xue L, Qi X, Bai Y, Wu Y. Gene networks and toxicity/detoxification pathways in juvenile largemouth bass (Micropterus salmoides) liver induced by acute lead stress. Genomics 2020;112:20-31. [DOI: 10.1016/j.ygeno.2019.06.023] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
39 Ebrahimiyan H, Mostafaei S, Aslani S, Faezi ST, Farhadi E, Jamshidi A, Mahmoudi M. Association between complement gene polymorphisms and systemic lupus erythematosus: a systematic review and meta-analysis. Clin Exp Med 2021. [PMID: 34519938 DOI: 10.1007/s10238-021-00758-0] [Reference Citation Analysis]
40 Endres D, Matysik M, Feige B, Venhoff N, Schweizer T, Michel M, Meixensberger S, Runge K, Maier SJ, Nickel K, Bechter K, Urbach H, Domschke K, Tebartz van Elst L. Diagnosing Organic Causes of Schizophrenia Spectrum Disorders: Findings from a One-Year Cohort of the Freiburg Diagnostic Protocol in Psychosis (FDPP). Diagnostics (Basel) 2020;10:E691. [PMID: 32937787 DOI: 10.3390/diagnostics10090691] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
41 Merle NS, Noe R, Halbwachs-Mecarelli L, Fremeaux-Bacchi V, Roumenina LT. Complement System Part II: Role in Immunity. Front Immunol 2015;6:257. [PMID: 26074922 DOI: 10.3389/fimmu.2015.00257] [Cited by in Crossref: 353] [Cited by in F6Publishing: 385] [Article Influence: 50.4] [Reference Citation Analysis]
42 Shao S, Hao C, Zhan B, Zhuang Q, Zhao L, Chen Y, Huang J, Zhu X. Trichinella spiralis Calreticulin S-Domain Binds to Human Complement C1q to Interfere With C1q-Mediated Immune Functions. Front Immunol 2020;11:572326. [PMID: 33329535 DOI: 10.3389/fimmu.2020.572326] [Reference Citation Analysis]
43 Schramm EC, Staten NR, Zhang Z, Bruce SS, Kellner C, Atkinson JP, Kyttaris VC, Tsokos GC, Petri M, Sander Connolly E, Olson PK. A quantitative lateral flow assay to detect complement activation in blood. Anal Biochem 2015;477:78-85. [PMID: 25660530 DOI: 10.1016/j.ab.2015.01.024] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 4.4] [Reference Citation Analysis]
44 Yuan X, Chang CY, You R, Shan M, Gu BH, Madison MC, Diehl G, Perusich S, Song LZ, Cornwell L, Rossen RD, Wetsel R, Kimal R, Coarfa C, Eltzschig HK, Corry DB, Kheradmand F. Cigarette smoke-induced reduction of C1q promotes emphysema. JCI Insight 2019;5:124317. [PMID: 31112138 DOI: 10.1172/jci.insight.124317] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
45 Elvington M, Liszewski MK, Liszewski AR, Kulkarni HS, Hachem RR, Mohanakumar T, Kim AHJ, Atkinson JP. Development and Optimization of an ELISA to Quantitate C3(H 2 O) as a Marker of Human Disease. Front Immunol 2019;10:703. [PMID: 31019515 DOI: 10.3389/fimmu.2019.00703] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
46 Munroe ME, James JA. Genetics of Lupus Nephritis: Clinical Implications. Semin Nephrol 2015;35:396-409. [PMID: 26573543 DOI: 10.1016/j.semnephrol.2015.08.002] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 3.5] [Reference Citation Analysis]
47 Yu Y, Zhu C, Zhou S, Chi S. Association Between C1q, TRAIL, and Tim-1 Gene Polymorphisms and Systemic Lupus Erythematosus. Genet Test Mol Biomarkers 2018;22:546-53. [PMID: 30183357 DOI: 10.1089/gtmb.2018.0056] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
48 Guo J, Gao Y, Wang Y, Zou Y, Du Y, Luo C, Shi Y, Yang Y, Wu X, Su Y, Wu L, Chen S, Li Z. Investigation of C1-complex regions reveals new C1Q variants associated with protection from systemic lupus erythematosus, and affect its transcript abundance. Sci Rep 2018;8:8048. [PMID: 29795138 DOI: 10.1038/s41598-018-26380-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
49 Seth G, Sundaresh A, Mariaselvam CM, Kumar G, Chengappa KG, Adarsh MB, Tamouza R, Negi VS. Immunological biomarkers in neuropsychiatric systemic lupus erythematosus: a comparative cross-sectional study from a tertiary care center in South India. Lupus 2020;29:413-20. [PMID: 32106787 DOI: 10.1177/0961203320908940] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
50 Son M, Kim SJ, Diamond B. SLE-associated risk factors affect DC function. Immunol Rev 2016;269:100-17. [PMID: 26683148 DOI: 10.1111/imr.12348] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
51 Biewenga M, Farina Sarasqueta A, Tushuizen ME, de Jonge-Muller ESM, van Hoek B, Trouw LA. The role of complement activation in autoimmune liver disease. Autoimmun Rev 2020;19:102534. [PMID: 32234403 DOI: 10.1016/j.autrev.2020.102534] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
52 Chen YW, Hsieh TY, Lin CH, Chen HM, Lin CC, Chen HH. Association Between a History of Dengue Fever and the Risk of Systemic Autoimmune Rheumatic Diseases: A Nationwide, Population-Based Case-Control Study. Front Med (Lausanne) 2021;8:738291. [PMID: 34805205 DOI: 10.3389/fmed.2021.738291] [Reference Citation Analysis]
53 Scherlinger M, Guillotin V, Truchetet ME, Contin-Bordes C, Sisirak V, Duffau P, Lazaro E, Richez C, Blanco P. Systemic lupus erythematosus and systemic sclerosis: All roads lead to platelets. Autoimmun Rev 2018;17:625-35. [PMID: 29635077 DOI: 10.1016/j.autrev.2018.01.012] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 9.5] [Reference Citation Analysis]
54 Hultström M, Frithiof R, Grip J, Lindelöf L, Rooijackers O, Pigazzini S, Niemi M, Cordioli M, Nkambule L, Maricic T, Ekdahl KN, Nilsson B, Lipcsey M, Zeberg H, Eriksson O. Genetic determinants of mannose-binding lectin activity predispose to thromboembolic complications in critical COVID-19. Nat Immunol 2022. [PMID: 35624204 DOI: 10.1038/s41590-022-01227-w] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
55 Rosenberger A, Sohns M, Friedrichs S, Hung RJ, Fehringer G, McLaughlin J, Amos CI, Brennan P, Risch A, Brüske I, Caporaso NE, Landi MT, Christiani DC, Wei Y, Bickeböller H. Gene-set meta-analysis of lung cancer identifies pathway related to systemic lupus erythematosus. PLoS One 2017;12:e0173339. [PMID: 28273134 DOI: 10.1371/journal.pone.0173339] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
56 Pellicano C, Miglionico M, Romaggioli L, Colalillo A, Vantaggio L, Napodano C, Callà C, Gulli F, Marino M, Basile U, Rosato E. Increased Complement Activation in Systemic Sclerosis Patients with Skin and Lung Fibrosis. JPM 2022;12:284. [DOI: 10.3390/jpm12020284] [Reference Citation Analysis]
57 Enocsson H, Gullstrand B, Eloranta ML, Wetterö J, Leonard D, Rönnblom L, Bengtsson AA, Sjöwall C. C-Reactive Protein Levels in Systemic Lupus Erythematosus Are Modulated by the Interferon Gene Signature and CRP Gene Polymorphism rs1205. Front Immunol 2020;11:622326. [PMID: 33584722 DOI: 10.3389/fimmu.2020.622326] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
58 Prechl J, Papp K, Hérincs Z, Péterfy H, Lóránd V, Szittner Z, Estonba A, Rovero P, Paolini I, Del Amo J, Uribarri M, Alcaro MC, Ruiz-Larrañaga O, Migliorini P, Czirják L. Serological and Genetic Evidence for Altered Complement System Functionality in Systemic Lupus Erythematosus: Findings of the GAPAID Consortium. PLoS One 2016;11:e0150685. [PMID: 26950932 DOI: 10.1371/journal.pone.0150685] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
59 López-Lera A, Corvillo F, Nozal P, Regueiro JR, Sánchez-Corral P, López-Trascasa M. Complement as a diagnostic tool in immunopathology. Semin Cell Dev Biol 2019;85:86-97. [PMID: 29292221 DOI: 10.1016/j.semcdb.2017.12.017] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
60 Hagberg N, Lundtoft C, Rönnblom L. Immunogenetics in systemic lupus erythematosus: Transitioning from genetic associations to cellular effects. Scand J Immunol 2020;92. [DOI: 10.1111/sji.12894] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
61 Arsov T, Sestan M, Cekada N, Frkovic M, Andrews D, He Y, Shen N, Vinuesa CG, Jelusic M. Systemic lupus erythematosus: A new autoimmune disorder in Kabuki syndrome. Eur J Med Genet 2019;62:103538. [PMID: 30213761 DOI: 10.1016/j.ejmg.2018.09.005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
62 Omarjee O, Picard C, Frachette C, Moreews M, Rieux-Laucat F, Soulas-Sprauel P, Viel S, Lega JC, Bader-Meunier B, Walzer T, Mathieu AL, Cimaz R, Belot A. Monogenic lupus: Dissecting heterogeneity. Autoimmun Rev 2019;18:102361. [PMID: 31401343 DOI: 10.1016/j.autrev.2019.102361] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 6.3] [Reference Citation Analysis]
63 Dasdemir S, Yildiz M, Celebi D, Sahin S, Aliyeva N, Haslak F, Gunalp A, Adrovic A, Barut K, Artim Esen B, Kasapcopur O. Genetic screening of early-onset patients with systemic lupus erythematosus by a targeted next-generation sequencing gene panel. Lupus 2022;:9612033221076733. [PMID: 35086391 DOI: 10.1177/09612033221076733] [Reference Citation Analysis]
64 Qiu J, Qin X, Wen J, Wu L, Kong L, Ou Y, Yang S. Single-nucleotide polymorphisms influence the promoter activities of systemic lupus erythematosus-associated genes. Biotechnol Lett 2020;42:1887-96. [PMID: 32451802 DOI: 10.1007/s10529-020-02916-y] [Reference Citation Analysis]
65 Lenna S, Assassi S, Farina GA, Mantero JC, Scorza R, Lafyatis R, Farber HW, Trojanowska M. The HLA-B*35 allele modulates ER stress, inflammation and proliferation in PBMCs from Limited Cutaneous Systemic Sclerosis patients. Arthritis Res Ther 2015;17:363. [PMID: 26669670 DOI: 10.1186/s13075-015-0881-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
66 Soni C, Sinha I, Fasnacht MJ, Olsen NJ, Rahman ZSM, Sinha R. Selenium supplementation suppresses immunological and serological features of lupus in B6.Sle1b mice. Autoimmunity 2019;52:57-68. [PMID: 31006265 DOI: 10.1080/08916934.2019.1603297] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
67 Wang S, Wu M, Chiriboga L, Zeck B, Belmont HM. Membrane attack complex (mac) deposition in lupus nephritis is associated with hypertension and poor clinical response to treatment. Semin Arthritis Rheum 2018;48:256-62. [PMID: 29395256 DOI: 10.1016/j.semarthrit.2018.01.004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
68 Hu L, Hu J, Chen L, Zhang Y, Wang Q, Yang X. Interleukin-22 From Type 3 Innate Lymphoid Cells Aggravates Lupus Nephritis by Promoting Macrophage Infiltration in Lupus-Prone Mice. Front Immunol 2021;12:584414. [PMID: 33717066 DOI: 10.3389/fimmu.2021.584414] [Reference Citation Analysis]
69 Xie CB, Qin L, Li G, Fang C, Kirkiles-Smith NC, Tellides G, Pober JS, Jane-Wit D. Complement Membrane Attack Complexes Assemble NLRP3 Inflammasomes Triggering IL-1 Activation of IFN-γ-Primed Human Endothelium. Circ Res 2019;124:1747-59. [PMID: 31170059 DOI: 10.1161/CIRCRESAHA.119.314845] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 7.7] [Reference Citation Analysis]
70 Su J, He J, Su Z, Zhou L, Zeng Y, Lai X, Li Y. T cell inhibition by pogostone from Pogostemon cablin (Blanco) Benth: In vitro and in vivo immunosuppressive analysis. Mol Med Rep 2017;16:4511-20. [PMID: 28791344 DOI: 10.3892/mmr.2017.7147] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
71 Svenungsson E, Gustafsson JT, Grosso G, Rossides M, Gunnarsson I, Jensen-Urstad K, Larsson A, Ekdahl KN, Nilsson B, Bengtsson AA, Lood C. Complement deposition, C4d, on platelets is associated with vascular events in systemic lupus erythematosus. Rheumatology (Oxford) 2020;59:3264-74. [PMID: 32259250 DOI: 10.1093/rheumatology/keaa092] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
72 Ren J, Cai R, Wang J, Daniyal M, Baimanov D, Liu Y, Yin D, Liu Y, Miao Q, Zhao Y, Chen C. Precision Nanomedicine Development Based on Specific Opsonization of Human Cancer Patient-Personalized Protein Coronas. Nano Lett 2019;19:4692-701. [DOI: 10.1021/acs.nanolett.9b01774] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 9.3] [Reference Citation Analysis]
73 Talsma DT, Poppelaars F, Dam W, Meter-Arkema AH, Vivès RR, Gál P, Boons GJ, Chopra P, Naggi A, Seelen MA, Berger SP, Daha MR, Stegeman CA, van den Born J; COMBAT Consortium. MASP-2 Is a Heparin-Binding Protease; Identification of Blocking Oligosaccharides. Front Immunol 2020;11:732. [PMID: 32425936 DOI: 10.3389/fimmu.2020.00732] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
74 Xu M, Liu Y, Li X, Cheng C, Liu Y, Dong W, Du S, Xiao S. Evaluation of genetic susceptibility between systemic lupus erythematosus and GRB2 gene. Sci Rep 2019;9:10335. [PMID: 31316132 DOI: 10.1038/s41598-019-46827-z] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
75 Porcelli SA. Innate Immunity. Kelley and Firestein's Textbook of Rheumatology. Elsevier; 2017. pp. 274-87. [DOI: 10.1016/b978-0-323-31696-5.00017-6] [Cited by in Crossref: 4] [Article Influence: 0.8] [Reference Citation Analysis]
76 Coutant F, Miossec P. Altered dendritic cell functions in autoimmune diseases: distinct and overlapping profiles. Nat Rev Rheumatol 2016;12:703-15. [DOI: 10.1038/nrrheum.2016.147] [Cited by in Crossref: 51] [Cited by in F6Publishing: 50] [Article Influence: 8.5] [Reference Citation Analysis]
77 Durcan L, Petri M. The clinical and serological associations of hypocomplementemia in a longitudinal sle cohort. Semin Arthritis Rheum 2020;50:1081-6. [PMID: 32916558 DOI: 10.1016/j.semarthrit.2020.06.009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
78 Caster DJ, Korte EA, Merchant ML, Klein JB, Wilkey DW, Rovin BH, Birmingham DJ, Harley JB, Cobb BL, Namjou B, McLeish KR, Powell DW. Autoantibodies targeting glomerular annexin A2 identify patients with proliferative lupus nephritis. Proteomics Clin Appl 2015;9:1012-20. [PMID: 25824007 DOI: 10.1002/prca.201400175] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 3.6] [Reference Citation Analysis]
79 Bohlson SS, O'Conner SD, Hulsebus HJ, Ho MM, Fraser DA. Complement, c1q, and c1q-related molecules regulate macrophage polarization. Front Immunol 2014;5:402. [PMID: 25191325 DOI: 10.3389/fimmu.2014.00402] [Cited by in Crossref: 106] [Cited by in F6Publishing: 104] [Article Influence: 13.3] [Reference Citation Analysis]
80 Grunenwald A, Roumenina LT. The Benefits of Complement Measurements for the Clinical Practice. Methods Mol Biol 2021;2227:1-20. [PMID: 33847926 DOI: 10.1007/978-1-0716-1016-9_1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
81 Wang X, Yan S, Liu C, Xu Y, Wan L, Wang Y, Gao W, Meng S, Liu Y, Liu R, Xu D. Fracture risk and bone mineral density levels in patients with systemic lupus erythematosus: a systematic review and meta-analysis. Osteoporos Int 2016;27:1413-23. [PMID: 26753541 DOI: 10.1007/s00198-015-3449-7] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 4.2] [Reference Citation Analysis]
82 Prechl J, Czirják L. The endothelial deprotection hypothesis for lupus pathogenesis: the dual role of C1q as a mediator of clearance and regulator of endothelial permeability. F1000Res 2015;4:24. [PMID: 25901277 DOI: 10.12688/f1000research.6075.2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
83 Kiss MG, Binder CJ. The multifaceted impact of complement on atherosclerosis. Atherosclerosis 2022. [DOI: 10.1016/j.atherosclerosis.2022.03.014] [Reference Citation Analysis]
84 La’ulu SL, Suh-lailam BB, Davis KW, Straseski JA, Tebo AE. Comparative analysis of neutrophil gelatinase-associated lipocalin and other laboratory markers for lupus nephritis: a cross-sectional investigation. Ann Clin Biochem 2017;54:240-5. [DOI: 10.1177/0004563216651888] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
85 Ghias MH, Hyde MJ, Tomalin LE, Morgan BP, Alavi A, Lowes MA, Piguet V. Role of the Complement Pathway in Inflammatory Skin Diseases: A Focus on Hidradenitis Suppurativa. J Invest Dermatol 2020;140:531-536.e1. [PMID: 31870626 DOI: 10.1016/j.jid.2019.09.009] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
86 Yu F, Haas M, Glassock R, Zhao MH. Redefining lupus nephritis: clinical implications of pathophysiologic subtypes. Nat Rev Nephrol. 2017;13:483-495. [PMID: 28669995 DOI: 10.1038/nrneph.2017.85] [Cited by in Crossref: 105] [Cited by in F6Publishing: 93] [Article Influence: 21.0] [Reference Citation Analysis]
87 Liang YY, Rainprecht D, Eichmair E, Messner B, Oehler R. Serum-dependent processing of late apoptotic cells and their immunogenicity. Apoptosis 2015;20:1444-56. [DOI: 10.1007/s10495-015-1163-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
88 Fathollahi A, Gabalou NB, Aslani S. Mesenchymal stem cell transplantation in systemic lupus erythematous, a mesenchymal stem cell disorder. Lupus. 2018;27:1053-1064. [PMID: 29631514 DOI: 10.1177/0961203318768889] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 4.5] [Reference Citation Analysis]
89 Grande MA, Belstrøm D, Damgaard C, Holmstrup P, Thangaraj SS, Nielsen CH, Palarasah Y. Complement split product C3c in saliva as biomarker for periodontitis and response to periodontal treatment. J Periodontal Res 2021;56:27-33. [PMID: 32681659 DOI: 10.1111/jre.12788] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
90 Ruacho G, Kvarnström M, Zickert A, Oke V, Rönnelid J, Eketjäll S, Elvin K, Gunnarsson I, Svenungsson E. Sjögren Syndrome in Systemic Lupus Erythematosus: A Subset Characterized by a Systemic Inflammatory State. J Rheumatol 2020;47:865-75. [PMID: 31523050 DOI: 10.3899/jrheum.190250] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
91 Woods M, Zou YR, Davidson A. Defects in Germinal Center Selection in SLE. Front Immunol 2015;6:425. [PMID: 26322049 DOI: 10.3389/fimmu.2015.00425] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 3.0] [Reference Citation Analysis]
92 Osthoff M, Jaeger VK, Heijnen IAFM, Trendelenburg M, Jordan S, Distler O, Walker UA. Role of lectin pathway complement proteins and genetic variants in organ damage and disease severity of systemic sclerosis: a cross-sectional study. Arthritis Res Ther 2019;21:76. [PMID: 30885245 DOI: 10.1186/s13075-019-1859-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
93 Morawski PA, Bolland S. Expanding the B Cell-Centric View of Systemic Lupus Erythematosus. Trends Immunol 2017;38:373-82. [PMID: 28274696 DOI: 10.1016/j.it.2017.02.001] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 4.4] [Reference Citation Analysis]
94 Bienstock D, Mandel L. Facial angioedema and systemic lupus erythematosus: case report. J Oral Maxillofac Surg 2015;73:928-32. [PMID: 25795187 DOI: 10.1016/j.joms.2014.12.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
95 Brahma R, Gurumayum S, Naorem LD, Muthaiyan M, Gopal J, Venkatesan A. Identification of Hub Genes and Pathways in Zika Virus Infection Using RNA-Seq Data: A Network-Based Computational Approach. Viral Immunol 2018;31:321-32. [PMID: 29608426 DOI: 10.1089/vim.2017.0116] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
96 Atkinson JP, Yu CY. The Complement System in Systemic Lupus Erythematosus. Systemic Lupus Erythematosus. Elsevier; 2016. pp. 81-112. [DOI: 10.1016/b978-0-12-801917-7.00012-7] [Cited by in Crossref: 3] [Article Influence: 0.5] [Reference Citation Analysis]
97 Javinani A, Ashraf-ganjouei A, Aslani S, Jamshidi A, Mahmoudi M. Exploring the etiopathogenesis of systemic lupus erythematosus: a genetic perspective. Immunogenetics 2019;71:283-97. [DOI: 10.1007/s00251-019-01103-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
98 Mack HG, Kowalski T, Lucattini A, Symons RA, Wicks I, Hall AJ. Genetic susceptibility to hydroxychloroquine retinal toxicity. Ophthalmic Genet 2020;41:159-70. [PMID: 32281450 DOI: 10.1080/13816810.2020.1747093] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
99 Ort M, Dingemanse J, van den Anker J, Kaufmann P. Treatment of Rare Inflammatory Kidney Diseases: Drugs Targeting the Terminal Complement Pathway. Front Immunol 2020;11:599417. [PMID: 33362783 DOI: 10.3389/fimmu.2020.599417] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
100 Amaya-Uribe L, Rojas M, Azizi G, Anaya JM, Gershwin ME. Primary immunodeficiency and autoimmunity: A comprehensive review. J Autoimmun 2019;99:52-72. [PMID: 30795880 DOI: 10.1016/j.jaut.2019.01.011] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 10.7] [Reference Citation Analysis]
101 Song L, Ge T, Li Z, Sun J, Li G, Sun Y, Fang L, Ma YJ, Garred P. Artesunate: A natural product-based immunomodulator involved in human complement. Biomed Pharmacother 2021;136:111234. [PMID: 33454596 DOI: 10.1016/j.biopha.2021.111234] [Reference Citation Analysis]
102 Fu W, Liu Y, Liu F, Liu C, Li J, Niu J, Han P, Xu D, Hou J, Ma Y, Feng J, Li Z, Mu R, Yang G. A Novel Autoantibody Induced by Bacterial Biofilm Conserved Components Aggravates Lupus Nephritis. Front Immunol 2021;12:656090. [PMID: 33841441 DOI: 10.3389/fimmu.2021.656090] [Reference Citation Analysis]
103 Prohászka Z, Nilsson B, Frazer-Abel A, Kirschfink M. Complement analysis 2016: Clinical indications, laboratory diagnostics and quality control. Immunobiology 2016;221:1247-58. [PMID: 27475991 DOI: 10.1016/j.imbio.2016.06.008] [Cited by in Crossref: 44] [Cited by in F6Publishing: 40] [Article Influence: 7.3] [Reference Citation Analysis]
104 Monzavi SM, Alirezaei A, Shariati-Sarabi Z, Tavakol Afshari J, Mahmoudi M, Dormanesh B, Jahandoost F, Khoshdel AR, Etemad Rezaie A. Efficacy analysis of hydroxychloroquine therapy in systemic lupus erythematosus: a study on disease activity and immunological biomarkers. Inflammopharmacology 2018;26:1175-82. [PMID: 29987550 DOI: 10.1007/s10787-018-0512-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
105 Segal Y, Calabrò M, Kanduc D, Shoenfeld Y. Human papilloma virus and lupus: the virus, the vaccine and the disease. Current Opinion in Rheumatology 2017;29:331-42. [DOI: 10.1097/bor.0000000000000398] [Cited by in Crossref: 23] [Cited by in F6Publishing: 8] [Article Influence: 4.6] [Reference Citation Analysis]
106 Wright RD, Bannerman F, Beresford MW, Oni L. A systematic review of the role of eculizumab in systemic lupus erythematosus-associated thrombotic microangiopathy. BMC Nephrol 2020;21:245. [PMID: 32605540 DOI: 10.1186/s12882-020-01888-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
107 Asif A, Nayer A, Haas CS. Atypical hemolytic uremic syndrome in the setting of complement-amplifying conditions: case reports and a review of the evidence for treatment with eculizumab. J Nephrol 2017;30:347-62. [PMID: 27848226 DOI: 10.1007/s40620-016-0357-7] [Cited by in Crossref: 43] [Cited by in F6Publishing: 41] [Article Influence: 7.2] [Reference Citation Analysis]
108 Son M, Diamond B, Santiago-Schwarz F. Fundamental role of C1q in autoimmunity and inflammation. Immunol Res 2015;63:101-6. [PMID: 26410546 DOI: 10.1007/s12026-015-8705-6] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 5.5] [Reference Citation Analysis]
109 Shukla A, Gaur P. Hereditary C1 inhibitor deficiency associated with systemic lupus erythematosus. Lupus 2020;29:1456-60. [PMID: 32659156 DOI: 10.1177/0961203320935980] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
110 Aringer M. Inflammatory markers in systemic lupus erythematosus. J Autoimmun 2020;110:102374. [PMID: 31812331 DOI: 10.1016/j.jaut.2019.102374] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 8.3] [Reference Citation Analysis]
111 Kremlitzka M, Mácsik-Valent B, Polgár A, Kiss E, Poór G, Erdei A. Complement Receptor Type 1 Suppresses Human B Cell Functions in SLE Patients. J Immunol Res 2016;2016:5758192. [PMID: 27981054 DOI: 10.1155/2016/5758192] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
112 Raymond W, Eilertsen G, Nossent J. Hypocomplementemia as a Risk Factor for Organ Damage Accrual in Patients with Systemic Lupus Erythematosus. J Immunol Res 2018;2018:8051972. [PMID: 30687766 DOI: 10.1155/2018/8051972] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
113 Capecchi R, Puxeddu I, Pratesi F, Migliorini P. New biomarkers in SLE: from bench to bedside. Rheumatology (Oxford) 2020;59:v12-8. [PMID: 32911542 DOI: 10.1093/rheumatology/keaa484] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
114 Larosa M, Iaccarino L, Gatto M, Punzi L, Doria A. Advances in the diagnosis and classification of systemic lupus erythematosus. Expert Rev Clin Immunol. 2016;12:1309-1320. [PMID: 27362864 DOI: 10.1080/1744666x.2016.1206470] [Cited by in Crossref: 22] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
115 Vasilev VV, Noe R, Dragon-Durey MA, Chauvet S, Lazarov VJ, Deliyska BP, Fremeaux-Bacchi V, Dimitrov JD, Roumenina LT. Functional Characterization of Autoantibodies against Complement Component C3 in Patients with Lupus Nephritis. J Biol Chem 2015;290:25343-55. [PMID: 26245903 DOI: 10.1074/jbc.M115.647008] [Cited by in Crossref: 29] [Cited by in F6Publishing: 17] [Article Influence: 4.1] [Reference Citation Analysis]
116 Trouw LA, Pickering MC, Blom AM. The complement system as a potential therapeutic target in rheumatic disease. Nat Rev Rheumatol 2017;13:538-47. [DOI: 10.1038/nrrheum.2017.125] [Cited by in Crossref: 95] [Cited by in F6Publishing: 84] [Article Influence: 19.0] [Reference Citation Analysis]
117 Cui J, Xie X. UCH-L1 Expressed by Podocytes: a Potentially Therapeutic Target for Lupus Nephritis? Inflammation 2017;40:657-65. [DOI: 10.1007/s10753-017-0512-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
118 Son M, Diamond B, Volpe BT, Aranow CB, Mackay MC, Santiago-Schwarz F. Evidence for C1q-mediated crosslinking of CD33/LAIR-1 inhibitory immunoreceptors and biological control of CD33/LAIR-1 expression. Sci Rep 2017;7:270. [PMID: 28325905 DOI: 10.1038/s41598-017-00290-w] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 5.4] [Reference Citation Analysis]
119 Pisetsky DS. Anti-DNA antibodies--quintessential biomarkers of SLE. Nat Rev Rheumatol 2016;12:102-10. [PMID: 26581343 DOI: 10.1038/nrrheum.2015.151] [Cited by in Crossref: 131] [Cited by in F6Publishing: 116] [Article Influence: 18.7] [Reference Citation Analysis]
120 González LA, Ugarte-Gil MF, Alarcón GS. Systemic lupus erythematosus: The search for the ideal biomarker. Lupus 2021;30:181-203. [PMID: 33307987 DOI: 10.1177/0961203320979051] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
121 Aso K, Kono M, Kono M, Watanabe T, Shimizu Y, Ogata Y, Fujieda Y, Kato M, Oku K, Amengual O, Yasuda S, Atsumi T. Low C4 as a risk factor for severe neuropsychiatric flare in patients with systemic lupus erythematosus. Lupus 2020;29:1238-47. [PMID: 32635880 DOI: 10.1177/0961203320938453] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
122 Hubbard EL, Pisetsky DS, Lipsky PE. Anti-RNP antibodies are associated with the interferon gene signature but not decreased complement levels in SLE. Ann Rheum Dis 2022:annrheumdis-2021-221662. [PMID: 35115332 DOI: 10.1136/annrheumdis-2021-221662] [Reference Citation Analysis]
123 Magro-checa C, Schaarenburg RA, Beaart HJL, Huizinga TWJ, Steup-beekman GM, Trouw LA. Complement levels and anti-C1q autoantibodies in patients with neuropsychiatric systemic lupus erythematosus. Lupus 2016;25:878-88. [DOI: 10.1177/0961203316643170] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
124 Ham YJ, Nicklason E, Wightman T, Akom S, Sandhu K, Harraka P, Colville D, Catran A, Barit D, Langsford D, Pianta T, Foote A, Buchanan R, Mack H, Savige J. Retinal drusen are more common and larger in SLE with renal impairment. Kidney International Reports 2022. [DOI: 10.1016/j.ekir.2022.01.1063] [Reference Citation Analysis]
125 Kim Y, Shim SC. Wolves Trapped in the NETs–The Pathogenesis of Lupus Nephritis. J Rheum Dis 2018;25:81. [DOI: 10.4078/jrd.2018.25.2.81] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
126 Brilland B, Scherlinger M, Khoryati L, Goret J, Duffau P, Lazaro E, Charrier M, Guillotin V, Richez C, Blanco P. Platelets and IgE: Shaping the Innate Immune Response in Systemic Lupus Erythematosus. Clinic Rev Allerg Immunol 2020;58:194-212. [DOI: 10.1007/s12016-019-08744-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
127 Keragala CB, Draxler DF, McQuilten ZK, Medcalf RL. Haemostasis and innate immunity - a complementary relationship: A review of the intricate relationship between coagulation and complement pathways. Br J Haematol 2018;180:782-98. [PMID: 29265338 DOI: 10.1111/bjh.15062] [Cited by in Crossref: 46] [Cited by in F6Publishing: 47] [Article Influence: 9.2] [Reference Citation Analysis]
128 Zhou Z, Ding M, Huang L, Gilkeson G, Lang R, Jiang W. Toll-like receptor-mediated immune responses in intestinal macrophages; implications for mucosal immunity and autoimmune diseases. Clin Immunol 2016;173:81-6. [PMID: 27620642 DOI: 10.1016/j.clim.2016.09.005] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
129 Picard C, Lega J, Ranchin B, Cochat P, Cabrera N, Fabien N, Belot A. Anti-C1q autoantibodies as markers of renal involvement in childhood-onset systemic lupus erythematosus. Pediatr Nephrol 2017;32:1537-45. [DOI: 10.1007/s00467-017-3646-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
130 Irure-ventura J, López-hoyos M. Disease criteria of systemic lupus erythematosus (SLE); the potential role of non-criteria autoantibodies. Journal of Translational Autoimmunity 2022;5:100143. [DOI: 10.1016/j.jtauto.2022.100143] [Reference Citation Analysis]
131 Lin J, Li N, Chen H, Liu C, Yang B, Ou Q. Serum Cyr61 is associated with clinical disease activity and inflammation in patients with systemic lupus erythematosus. Medicine (Baltimore) 2015;94:e834. [PMID: 25984669 DOI: 10.1097/MD.0000000000000834] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
132 Hartl J, Serpas L, Wang Y, Rashidfarrokhi A, Perez OA, Sally B, Sisirak V, Soni C, Khodadadi-Jamayran A, Tsirigos A, Caiello I, Bracaglia C, Volpi S, Ghiggeri GM, Chida AS, Sanz I, Kim MY, Belmont HM, Silverman GJ, Clancy RM, Izmirly PM, Buyon JP, Reizis B. Autoantibody-mediated impairment of DNASE1L3 activity in sporadic systemic lupus erythematosus. J Exp Med 2021;218:e20201138. [PMID: 33783474 DOI: 10.1084/jem.20201138] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
133 Yu H, Nagafuchi Y, Fujio K. Clinical and Immunological Biomarkers for Systemic Lupus Erythematosus. Biomolecules 2021;11:928. [PMID: 34206696 DOI: 10.3390/biom11070928] [Reference Citation Analysis]
134 Bolouri N, Akhtari M, Farhadi E, Mansouri R, Faezi ST, Jamshidi A, Mahmoudi M. Role of the innate and adaptive immune responses in the pathogenesis of systemic lupus erythematosus. Inflamm Res 2022. [PMID: 35298669 DOI: 10.1007/s00011-022-01554-6] [Reference Citation Analysis]